Details for 2017739696

Up to date per 04.04.2026

Actions

Title / Product Name

KRISTALLINE FORM DES (R)-4-(5-(CYCLOPROPYLETHYNYL)ISOXAZOL-3-YL)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)BUTANAMIDS ALS ANTIBAKTERIELLER WIRKSTOFF

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017739696

EP Publication Number

3468957

E-Number

1306243

Language

PCT Number

IB17053468

Publication Date

17.04.2019 A

26.08.2020 B1

Registration Date

26.08.2020

AT Publication Date

15.09.2020

Application Date

12.06.2017

Registration Number

Priorities

14.06.2016

PCT/CN2016/085694

IPC

C07D 261/08 20060101AFI20171222BHEP

Maximum Duration of Protection

12.06.2037

Owner

NOVARTIS AGLichtstrasse 35 4056 BaselCH

Representative

Barger W. Dipl.Ing., Israiloff P. Dipl.Ing. Dr. techn.Operngasse 41010 WienAT

Inventor

FU, JipingNovartis Institutes for BioMedical Research Inc. 5300 Chiron Way Emeryville, California 94608US

JIANG, SiyiBeijing Novartis Pharma Co. Ltd. 4218 Jinke Road Zhangjiang Hi-Tech Park Shanghai 201203CN

KORDIKOWSKI, AndreasNovartis Pharma AG Postfach CH-4002 BaselCH

SWEENEY, Zachary Kevin143 King Street Redwood City, California 94602US